Drugs / Heparina
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00484822 Comparator | Feb 2007 → May 2009 | — | Sant Pau Research Institute | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heparina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00484822 ↗ |
| Known as | Heparina Cálcica | “Drug: Heparina Cálcica” NCT00484822 ↗ |